Slide 1Statistical Considerations for Implementing the FDA CV Guidance for T2DM Craig Wilson, PhD NIC-ASA Fall Meeting October 15, 2009 Slide 2 Regulatory History (1) Rosiglitazone…

Slide 1CHRONIC KIDNEY DISEAS Hisham Abdelwahab MRCP U.K MMed/SCI Slide 2 Slide 3 Slide 4 Slide 5 Common presentation of CKD Asymptomatic urine abnormalities : proteinuria/…

Slide 1Università degli Studi di Catanzaro Magna Græcia Slide 2 Slide 3 Slide 4 V ASCULAR R EMODELING Active process of structural alteration that involves cell growth…

Slide 1The Treatment of Advanced Heart Failure Shiva Roy FRACP POWH Nov 2000 Slide 2 Heart Failure: where are we now? P P CCF is a major health problem » »400,000 new cases…

Slide 1Your Approach to Heart failure and Arrhythmias in Diabetics Dr Mervat Aboulmaaty Professor of Cardiology Ain Shams University 2012 Slide 2 DIAGNOSIS OF HEART FAILURE…

Slide 1Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation – TIMI 48 Primary Results Robert P. Giugliano, MD, SM, FAHA, FACC On behalf of the…

1. Teaching an old dog new tricks – telehealth, IT, and diabetes management in the Mississippi Delta Marshall Bouldin MD Director, Diabetes and Metabolism Program Associate…

1. Department of Medicine Division of Nephrology Journal Club Sridhar Reddy Allam, MD, MPH Nephrology Fellow Mount Sinai School of Medicine       July 14, 2010 2. Clin…

Boala cardiovasculara la pacientii cu diabet zaharat Diabetic macrovascular disease (atherosclerotic cardiovascular disease in diabetic patients) Assist. lect. dr. Ariel…

Slide 1Dr. R. V. S. N. Sarma., M.D., M.Sc., (Canada) Consultant Physician and Chest Specialist www.drsarma.in 1 Slide 2 2 www.drsarma.in Slide 3 3 Slide 4 What types of lesions…